Accès ouvert
2026
article
OpenAlex
Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, Toshinori Hyodo et autres
Abstract KRAS mutations are significant drivers in various cancers, and existing drug discovery attempts targeting these mutations have largely been unsuccessful, emphasizing the need for more effective therapies. In this study, the screening library, which contains 1,374 chemical compounds, identified nintedanib, a …
jp, bd, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, Toshinori Hyodo et autres
Abstract KRAS mutations are significant drivers in various cancers, and existing drug discovery attempts targeting these mutations have largely been unsuccessful, emphasizing the need for more effective therapies. In this study, the screening library, which contains 1,374 chemical compounds, identified nintedanib, a …
jp, bd, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, Hideki Murakami et autres
Pleural mesothelioma (PM) is an uncommon yet deadly cancer linked to asbestos exposure. The lack of effective early diagnosis and treatment leads to reduced life expectancy among patients with PM. This study aims to identify a novel molecular target inhibitor to develop …
jp, bd, us
(code pays fourni par la source)
2025
article
OpenAlex
Md Towhid Ahmed Shihan, Toshinori Hyodo, Takeshi Fujino, Md Lutfur Rahman et autres
jp
(code pays fourni par la source)
2025
article
OpenAlex
Muhammad Nazmul Hasan
International audience
2025
article
OpenAlex
Bushra Moiz, Muhammad Nazmul Hasan, Muhammad Umar Salman, Bhawna Kumari et autres
Abstract LW a , LW ab , LW b , and LWEM are the four main antigens of the Landsteiner–Weiner (LW) blood group system. LW expression may be weakened during pregnancy and immune dysregulation, with the subsequent appearance of anti-LW. Here, we …
pk, au
(code pays fourni par la source)
Accès ouvert
2024
erratum
OpenAlex
Muhammad Nazmul Hasan, Bushra Moiz, Shama Qaiser, Kiran Iqbal Masood et autres
[This corrects the article DOI: 10.1371/journal.pone.0271259.].
pt
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, Hideki Murakami et autres
Abstract Malignant pleural mesothelioma (MPM) is an uncommon yet deadly cancer linked to asbestos exposure. The lack of effective early diagnosis and treatment leads to reduced life expectancy among patients with MPM. This study is aimed to identify a novel molecular target …
jp, bd, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, Lam Quang Vu et autres
5' adenosine monophosphate-activated protein kinase-related kinase 5 (ARK5) is involved in mitochondrial ATP production and associated with poor prognosis of multiple myeloma (MM). However, the molecular mechanisms of ARK5 in MM remain largely unknown. This study examined the pathogenic role of ARK5 …
jp, us, bd
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Toshinori Hyodo, Eri Asano‐Inami, Satoko Ito, Mai Sugiyama et autres
There has been a great deal of research on cell division and its mechanisms; however, its processes still have many unknowns. To find novel proteins that regulate cell division, we performed the screening using siRNAs and/or the expression plasmid of the target …
jp, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Muhammad Nazmul Hasan, Toshinori Hyodo, Mrityunjoy Biswas, Md Lutfur Rahman et autres
CRISPR/Cas9 is a powerful genome editing system that has remarkably facilitated gene knockout and targeted knock-in. To accelerate the practical use of CRISPR/Cas9, however, it remains crucial to improve the efficiency, precision, and specificity of genome editing, particularly targeted knock-in, achieved with …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Sivasundaram Karnan, Akinobu Ota, Hideki Murakami, Md Lutfur Rahman et autres
Malignant mesothelioma (MMe) is a rare but aggressive malignancy. Although the molecular genetics of MMe is known, including BRCA1-associated protein-1 (BAP1) gene alterations, the prognosis of MMe patients remains poor. Here, we generated BAP1 knockout (BAP1-KO) human mesothelial cell clones to develop …
jp, us
(code pays fourni par la source)